14 reports of this reaction
2.7% of all CAMPHOR, EUCALYPTUS OIL, MENTHOL reports
#4 most reported adverse reaction
DYSPNOEA is the #4 most commonly reported adverse reaction for CAMPHOR, EUCALYPTUS OIL, MENTHOL, manufactured by Wal-Mart Stores Inc. There are 14 FDA adverse event reports linking CAMPHOR, EUCALYPTUS OIL, MENTHOL to DYSPNOEA. This represents approximately 2.7% of all 525 adverse event reports for this drug.
Patients taking CAMPHOR, EUCALYPTUS OIL, MENTHOL who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for CAMPHOR, EUCALYPTUS OIL, MENTHOL, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for CAMPHOR, EUCALYPTUS OIL, MENTHOL:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 14 FDA reports for CAMPHOR, EUCALYPTUS OIL, MENTHOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 2.7% of all adverse event reports for CAMPHOR, EUCALYPTUS OIL, MENTHOL, making it a notable side effect.
If you experience dyspnoea while taking CAMPHOR, EUCALYPTUS OIL, MENTHOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.